Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028354865> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2028354865 endingPage "2911" @default.
- W2028354865 startingPage "2905" @default.
- W2028354865 abstract "The growth inhibitory effects of 5-fluorouracil (FUra) or 5-fluoro-2'-deoxyuridine (FdUrd) combined with 5-methyltetrahydrofolate (5-CH3-H4PteGlu) were determined, as a function of time, dose, and sequence of exposure, on human T-lymphoblast leukemia cells, CCRF-CEM. Synergistic inhibitory effects on cell growth were obtained when exponentially growing CCRF-CEM cells were exposed to 5-CH3-H4PteGlu (1-100 microM) for 4 hr and to FUra (250 microM) or FdUrd (0.5 microM) during the last 2 hr. Synergism was dependent on 5-CH3-H4PteGlu dose (100 greater than 10 greater than 1 microM) and did not occur at 0.1 microM. No clear dependence of synergism on sequence was observed with FUra and 5-CH3-H4PteGlu combinations (5-CH3-H4PteGlu----FUra,5-CH3-H4PteGlu + FUra, or FUra----5-CH3-H4PteGlu). With 5-CH3-H4PteGlu and FdUrd combinations, synergism was dependent on sequence of exposure (5-CH3-H4PteGlu + FdUrd, 5-CH3-H4PteGlu----FdUrd were synergistic, but FdUrd----5-CH3-H4PteGlu was not). Thymidine (0.1 microM), added after drug treatment, substantially rescued CCRF-CEM cells from 5-CH3-H4PteGlu----FUra cytotoxicity. L-methionine (1500 mg/l) completely protected CCRF-CEM cells from enhanced cytotoxicity of the combination, 5-CH3-H4PteGlu-FdUrd. The results are consistent with the hypothesis that the mechanism by which 5-CH3-H4PteGlu potentiates fluoropyrimidine cytotoxicity is the enhancement of complex formation between thymidylate synthase and 5-fluorodeoxyuridylate, as a consequence of an increase of intracellular levels of 5,10-methylenetetrahydrofolate generated from 5-CH3-H4PteGlu. Also, enhanced stability of the complex in the presence of high levels of this folate coenzyme may contribute to the synergism observed. These data provide a rationale basis for further trials of folate coenzymes and fluoropyrimidine combinations in the clinic." @default.
- W2028354865 created "2016-06-24" @default.
- W2028354865 creator A5012047866 @default.
- W2028354865 creator A5027182354 @default.
- W2028354865 creator A5042372248 @default.
- W2028354865 creator A5051728890 @default.
- W2028354865 creator A5068074391 @default.
- W2028354865 creator A5088995507 @default.
- W2028354865 creator A5055273163 @default.
- W2028354865 date "1987-09-01" @default.
- W2028354865 modified "2023-09-27" @default.
- W2028354865 title "Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells" @default.
- W2028354865 cites W1487046624 @default.
- W2028354865 cites W1489023860 @default.
- W2028354865 cites W1524929003 @default.
- W2028354865 cites W1575223772 @default.
- W2028354865 cites W1597762899 @default.
- W2028354865 cites W1878265365 @default.
- W2028354865 cites W1968400447 @default.
- W2028354865 cites W1995891215 @default.
- W2028354865 cites W2001865510 @default.
- W2028354865 cites W2006416369 @default.
- W2028354865 cites W2028875508 @default.
- W2028354865 cites W2029622134 @default.
- W2028354865 cites W2053679855 @default.
- W2028354865 cites W2080106203 @default.
- W2028354865 cites W2087491576 @default.
- W2028354865 cites W2097033810 @default.
- W2028354865 cites W2162199644 @default.
- W2028354865 cites W2166686502 @default.
- W2028354865 cites W2167847781 @default.
- W2028354865 cites W2408913764 @default.
- W2028354865 cites W2976955281 @default.
- W2028354865 doi "https://doi.org/10.1016/0006-2952(87)90201-2" @default.
- W2028354865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2958010" @default.
- W2028354865 hasPublicationYear "1987" @default.
- W2028354865 type Work @default.
- W2028354865 sameAs 2028354865 @default.
- W2028354865 citedByCount "28" @default.
- W2028354865 countsByYear W20283548652015 @default.
- W2028354865 crossrefType "journal-article" @default.
- W2028354865 hasAuthorship W2028354865A5012047866 @default.
- W2028354865 hasAuthorship W2028354865A5027182354 @default.
- W2028354865 hasAuthorship W2028354865A5042372248 @default.
- W2028354865 hasAuthorship W2028354865A5051728890 @default.
- W2028354865 hasAuthorship W2028354865A5055273163 @default.
- W2028354865 hasAuthorship W2028354865A5068074391 @default.
- W2028354865 hasAuthorship W2028354865A5088995507 @default.
- W2028354865 hasConcept C109316439 @default.
- W2028354865 hasConcept C185592680 @default.
- W2028354865 hasConcept C202751555 @default.
- W2028354865 hasConcept C55493867 @default.
- W2028354865 hasConcept C71924100 @default.
- W2028354865 hasConcept C98274493 @default.
- W2028354865 hasConceptScore W2028354865C109316439 @default.
- W2028354865 hasConceptScore W2028354865C185592680 @default.
- W2028354865 hasConceptScore W2028354865C202751555 @default.
- W2028354865 hasConceptScore W2028354865C55493867 @default.
- W2028354865 hasConceptScore W2028354865C71924100 @default.
- W2028354865 hasConceptScore W2028354865C98274493 @default.
- W2028354865 hasIssue "18" @default.
- W2028354865 hasLocation W20283548651 @default.
- W2028354865 hasLocation W20283548652 @default.
- W2028354865 hasOpenAccess W2028354865 @default.
- W2028354865 hasPrimaryLocation W20283548651 @default.
- W2028354865 hasRelatedWork W2034153247 @default.
- W2028354865 hasRelatedWork W2037614885 @default.
- W2028354865 hasRelatedWork W2048313550 @default.
- W2028354865 hasRelatedWork W2054720663 @default.
- W2028354865 hasRelatedWork W2054837357 @default.
- W2028354865 hasRelatedWork W2061950774 @default.
- W2028354865 hasRelatedWork W2091148514 @default.
- W2028354865 hasRelatedWork W2099695171 @default.
- W2028354865 hasRelatedWork W2525456170 @default.
- W2028354865 hasRelatedWork W3186112097 @default.
- W2028354865 hasVolume "36" @default.
- W2028354865 isParatext "false" @default.
- W2028354865 isRetracted "false" @default.
- W2028354865 magId "2028354865" @default.
- W2028354865 workType "article" @default.